Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Matinas Biopharma Holdings, Inc. (MTNB) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.66M |
|
-- |
|
-- |
|
$1.95M |
|
$-1.95M |
|
$0.29M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
$-1.95M |
|
$-1.82M |
|
5.09M |
|
5.09M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$7.55M |
|
$0.45M |
|
$4.49M |
|
$12.04M |
|
$2.25M |
|
$0.01M |
|
$3.51M |
|
$5.76M |
|
$6.27M |
|
$6.27M |
|
$6.27M |
|
5.09M |
|
| Cash Flow Statement Financials | |
$-2.01M |
|
-- |
|
$1.65M |
|
$7.53M |
|
$7.17M |
|
$-0.36M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.35 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.41% |
|
-26.41% |
|
-13.76% |
|
-26.37% |
|
$1.23 |
|
$-0.39 |
|
$-0.39 |
|